Pages that link to "Q34415030"
Jump to navigation
Jump to search
The following pages link to Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial (Q34415030):
Displaying 50 items.
- The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies (Q21129302) (← links)
- Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses (Q21144710) (← links)
- Epidemiology and natural history of human papillomavirus infections in the female genital tract (Q21284469) (← links)
- Global cancer statistics (Q22241238) (← links)
- Papillomavirus genome structure, expression, and post-transcriptional regulation (Q22255483) (← links)
- Prophylactic human papillomavirus vaccines (Q24545449) (← links)
- Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera (Q24545868) (← links)
- Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future (Q24600011) (← links)
- Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males (Q24614644) (← links)
- Virus-like particles production in green plants (Q24650772) (← links)
- Human papillomavirus and HPV vaccines: a review (Q24657891) (← links)
- The viral etiology of AIDS-associated malignancies (Q24685892) (← links)
- Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant (Q24802323) (← links)
- How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked? (Q25257230) (← links)
- Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline (Q26749285) (← links)
- The clinical development process for a novel preventive vaccine: An overview (Q26770871) (← links)
- Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease (Q26777330) (← links)
- Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV (Q26783973) (← links)
- Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus (Q26799574) (← links)
- Cervical Cancer (Q26851311) (← links)
- Cervical cancer control for Hispanic women in Texas: strategies from research and practice (Q26851681) (← links)
- Human papillomavirus vaccination: a case study in translational science (Q26853556) (← links)
- Current status of human papillomavirus vaccines (Q26991640) (← links)
- Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins (Q27013018) (← links)
- Are the currently existing anti-human papillomavirus vaccines appropriate for the developing world? (Q27692056) (← links)
- Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial (Q28236008) (← links)
- The human papillomavirus vaccine in Canada (Q28278978) (← links)
- VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus (Q28280059) (← links)
- Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors (Q28282622) (← links)
- Vaccines for tumour prevention (Q28299036) (← links)
- Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE) (Q28476101) (← links)
- Intranasal immunization with recombinant Lactococci carrying human papillomavirus E7 protein and mouse interleukin-12 DNA induces E7-specific antitumor effects in C57BL/6 mice (Q28660843) (← links)
- Capsomer vaccines protect mice from vaginal challenge with human papillomavirus (Q28743261) (← links)
- Difficulties in the prevention of cervical cancer: adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in Hungary (Q30226559) (← links)
- Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries (Q30230410) (← links)
- HPV-related external genital lesions among men residing in Brazil (Q30252655) (← links)
- Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. (Q30372990) (← links)
- Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer (Q30409053) (← links)
- Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong (Q31131825) (← links)
- New quadrivalent HPV vaccine developments (Q33156844) (← links)
- Safety of human papillomavirus vaccines: a review. (Q33162724) (← links)
- Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications (Q33233438) (← links)
- Alternative technologies in cervical cancer screening: a randomised evaluation trial (Q33260497) (← links)
- A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent (Q33273063) (← links)
- Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa (Q33284467) (← links)
- Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials (Q33292779) (← links)
- Warts (genital) (Q33448263) (← links)
- Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model (Q33488325) (← links)
- A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females (Q33514126) (← links)
- Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan (Q33523171) (← links)